X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6420) 6420
Publication (470) 470
Book Review (127) 127
Magazine Article (24) 24
Book / eBook (13) 13
Book Chapter (9) 9
Conference Proceeding (3) 3
Dissertation (3) 3
Newspaper Article (3) 3
Data Set (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6248) 6248
female (3954) 3954
index medicus (2793) 2793
hemorrhage - chemically induced (2466) 2466
male (2419) 2419
anticoagulants - adverse effects (2243) 2243
middle aged (2220) 2220
aged (2003) 2003
risk factors (1994) 1994
thromboembolism (1810) 1810
thromboembolism - chemically induced (1790) 1790
adult (1777) 1777
venous thromboembolism (1586) 1586
anticoagulants - therapeutic use (1446) 1446
thromboembolism - prevention & control (1232) 1232
anticoagulants - administration & dosage (1171) 1171
hematology (1128) 1128
treatment outcome (1068) 1068
thrombosis (1036) 1036
risk (996) 996
anticoagulants (993) 993
peripheral vascular disease (929) 929
warfarin (872) 872
medicine, general & internal (814) 814
aged, 80 and over (787) 787
prevention (748) 748
administration, oral (706) 706
risk assessment (689) 689
retrospective studies (674) 674
heparin - adverse effects (661) 661
contraceptives, oral - adverse effects (660) 660
time factors (632) 632
warfarin - adverse effects (625) 625
thromboembolism - etiology (620) 620
adolescent (589) 589
deep-vein thrombosis (580) 580
therapy (576) 576
venous thromboembolism - prevention & control (535) 535
cardiac & cardiovascular systems (519) 519
incidence (515) 515
abridged index medicus (507) 507
stroke (504) 504
surgery (500) 500
thromboembolism - drug therapy (493) 493
molecular-weight heparin (484) 484
pregnancy (458) 458
venous thromboembolism - chemically induced (451) 451
warfarin - therapeutic use (445) 445
anticoagulation (444) 444
prospective studies (438) 438
venous thromboembolism - drug therapy (433) 433
pharmacology & pharmacy (426) 426
heparin - therapeutic use (419) 419
animals (417) 417
thrombocytopenia - chemically induced (417) 417
atrial fibrillation - drug therapy (413) 413
care and treatment (412) 412
blood coagulation - drug effects (409) 409
randomized controlled trials as topic (407) 407
dabigatran (404) 404
thromboembolism - epidemiology (404) 404
drug therapy (403) 403
atrial fibrillation (399) 399
bleeding (398) 398
heparin (397) 397
follow-up studies (396) 396
hemorrhage (382) 382
drug administration schedule (378) 378
fibrinolytic agents - adverse effects (372) 372
pulmonary-embolism (371) 371
venous thrombosis (370) 370
rivaroxaban (369) 369
recurrence (360) 360
warfarin - administration & dosage (360) 360
mortality (359) 359
dose-response relationship, drug (354) 354
management (352) 352
heparin, low-molecular-weight - adverse effects (351) 351
atrial fibrillation - complications (345) 345
stroke - prevention & control (341) 341
pulmonary embolism (339) 339
analysis (336) 336
atrial-fibrillation (336) 336
hemorrhage - prevention & control (330) 330
cancer (329) 329
heparin, low-molecular-weight - therapeutic use (329) 329
enoxaparin (321) 321
hemorrhage - epidemiology (321) 321
international normalized ratio (316) 316
oncology (315) 315
obstetrics & gynecology (311) 311
venous thrombosis - chemically induced (311) 311
postoperative complications - prevention & control (310) 310
safety (310) 310
fibrinolytic agents - therapeutic use (308) 308
vitamin k - antagonists & inhibitors (302) 302
health aspects (301) 301
venous thromboembolism - etiology (297) 297
complications (293) 293
medicine & public health (278) 278
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5630) 5630
German (306) 306
French (187) 187
Spanish (50) 50
Russian (46) 46
Italian (34) 34
Swedish (31) 31
Danish (30) 30
Hungarian (20) 20
Japanese (20) 20
Czech (19) 19
Polish (19) 19
Norwegian (17) 17
Dutch (15) 15
Chinese (7) 7
Croatian (7) 7
Finnish (6) 6
Hebrew (6) 6
Portuguese (5) 5
Bulgarian (4) 4
Lithuanian (2) 2
Romanian (2) 2
Serbian (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CA: A Cancer Journal for Clinicians, ISSN 0007-9235, 07/2013, Volume 63, Issue 4, pp. 249 - 279
Answer questions and earn CME/CNE Advances in genomics and molecular biology have identified aberrant proteins in cancer cells that are attractive targets for... 
toxicity | kinase inhibitors | therapeutic index | targeted agents | mechanism‐based toxicity | immunotherapeutic agents | off‐target toxicity | mechanism-based toxicity | off-target toxicity | MEK INHIBITOR TRAMETINIB | PULMONARY ARTERIAL-HYPERTENSION | I DOSE-ESCALATION | CHRONIC MYELOID-LEUKEMIA | GROWTH-FACTOR RECEPTOR | ONCOLOGY | PLACEBO-CONTROLLED TRIAL | III CLINICAL-TRIAL | SQUAMOUS-CELL CARCINOMAS | TIVANTINIB ARQ 197 | SIGNAL-REGULATED KINASE | Mood Disorders - chemically induced | Drug Eruptions - etiology | Peripheral Nervous System Diseases - chemically induced | Bone Marrow Diseases - chemically induced | Cachexia - chemically induced | Endocrine System Diseases - chemically induced | Pleural Effusion - chemically induced | Humans | Drug Eruptions - therapy | Immune System Diseases - chemically induced | Lung Diseases, Interstitial - chemically induced | Thrombocytopenia - chemically induced | Diarrhea - chemically induced | Neoplasms - drug therapy | Antineoplastic Agents - adverse effects | Exanthema - chemically induced | Hyperbilirubinemia - chemically induced | Venous Thromboembolism - chemically induced | Vision Disorders - chemically induced | Hemorrhage - chemically induced | Heart Diseases - chemically induced | Hyperlipidemias - chemically induced | Magnesium - blood | Antimitotic agents | Drugs | Prevention | Complications and side effects | Drug targeting | Antineoplastic agents | Health aspects | Risk factors | Proteins | Side effects | Genomics | Cytotoxicity | Molecular biology | Cancer therapies | Cells | Index Medicus | Abridged Index Medicus
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 2011, Volume 103, Issue 17, pp. 1299 - 1309
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 01/2017, Volume 2017, Issue 1, p. CD004143
Journal Article
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 1/2010, Volume 102, Issue 1, pp. 14 - 25
Due to the aging of the populations of developed countries and a common occurrence of risk factors, it is increasingly probable that a patient may have both... 
DOXORUBICIN-INDUCED CARDIOTOXICITY | TRASTUZUMAB-RELATED CARDIOTOXICITY | ONCOLOGY | SPORADIC COLORECTAL ADENOMAS | VASCULAR-DISRUPTING AGENTS | TYROSINE KINASE INHIBITOR | N-ACETYLCYSTEINE | DAUNORUBICIN-INDUCED CYTOTOXICITY | HIGH-DOSE CHEMOTHERAPY | EARLY BREAST-CANCER | ATRIAL-FIBRILLATION | Atrial Fibrillation - chemically induced | Cardiovascular Diseases - prevention & control | Humans | Patient Care Team | Atrial Fibrillation - physiopathology | Ventricular Dysfunction, Left - chemically induced | Flavonoids - therapeutic use | Cardiotonic Agents - therapeutic use | Venous Thromboembolism - prevention & control | Cardiovascular System - physiopathology | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Antineoplastic Agents - adverse effects | Hypertension - chemically induced | Hypertension - prevention & control | Polyphenols | Free Radical Scavengers - therapeutic use | Acetylcysteine - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Cardiovascular Diseases - diagnosis | Heart - physiopathology | Cardiovascular Diseases - physiopathology | Stroke Volume - drug effects | Anticoagulants - therapeutic use | Cardiovascular System - drug effects | Hypertension - physiopathology | Ventricular Dysfunction, Left - physiopathology | Ventricular Dysfunction, Left - prevention & control | Cardiovascular Diseases - microbiology | Animals | Blood Coagulation - drug effects | Venous Thromboembolism - physiopathology | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Phenols - therapeutic use | Venous Thromboembolism - chemically induced | Heart - drug effects | Cardiovascular Diseases - chemically induced | Atrial Fibrillation - prevention & control | Antimitotic agents | Complications and side effects | Aging | Physiological aspects | Dosage and administration | Research | Cardiovascular diseases | Antineoplastic agents | Risk factors | Index Medicus | Review
Journal Article